High Hopes: Vaccine Update with J&J CEO Alex Gorsky at CNBC Healthy Returns
Johnson & Johnson's Covid-19 vaccine is being hailed as a potential "game changer," because of its single dose. We receive an update from the company's CEO Alex Gorsky on the status of FDA approval, along with an exclusive look into the process of developing a life-saving vaccine. He joins Meg Tirrell for this CNBC Healthy Returns Spotlight session on February 9, 2021.
Tue, Feb 9 20213:48 PM EST